Characterising the metabolic fate of (2S, 4R)-4[19F]-fluoroglutamine in cancer cells using 19F-MRS

被引：0

作者：

Nhat Nguyen ^{[1
]}

Doepner, Andreas ^{[1
]}

Smith, Graham ^{[1
]}

Chung, Yuen-Li ^{[1
]}

机构：

[1] Inst Canc Res, Sutton, Surrey, England

来源：

BRITISH JOURNAL OF CANCER | 2018年 / 119卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：30 / 30

页数：1

共 50 条

[31] EXPLOITING GLUTAMINE CONSUMPTION IN INFLAMED ATHEROSCLEROTIC LESIONS BY POSITRON EMISSION TOMOGRAPHY TRACER (2S, 4R)-4-[18F]FLUOROGLUTAMINE
Palani, S.
Virta, J.
Liljenback, H.
Miner, M. W.
Li, X. G.
Knuuti, J.
Saraste, A.
Roivainen, A.
ATHEROSCLEROSIS, 2021, 331 : E31 - E32
[32] (2S, 4R)-4-[18F]Fluoroglutamine for In vivo PET Imaging of Glioma Xenografts in Mice: an Evaluation of Multiple Pharmacokinetic Models
Maxwell WG Miner
Heidi Liljenbäck
Jenni Virta
Joni Merisaari
Vesa Oikonen
Jukka Westermarck
Xiang-Guo Li
Anne Roivainen
Molecular Imaging and Biology, 2020, 22 : 969 - 978
[33] Evaluation of (2S, 4R)- and (2S, 4S)-4[18F]Fluoro-L-glutamine as tumor metabolic imaging agents
Ploessl, Karl
Wang, Limin
Lieberman, Brian
Qu, Wenchao
Kung, Hank
JOURNAL OF NUCLEAR MEDICINE, 2011, 52
[34] (2S, 4R)-4-[18F]Fluoroglutamine for In vivo PET Imaging of Glioma Xenografts in Mice: an Evaluation of Multiple Pharmacokinetic Models
Miner, Maxwell W. G.
Liljenback, Heidi
Virta, Jenni
Merisaari, Joni
Oikonen, Vesa
Westermarck, Jukka
Li, Xiang-Guo
Roivainen, Anne
MOLECULAR IMAGING AND BIOLOGY, 2020, 22 (04) : 969 - 978
[35] In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of 18F-(2S,4R)-4-Fluoroglutamine
Dunphy, Mark P. S.
Harding, James J.
Venneti, Sriram
Zhang, Hanwen
Burnazi, Eva M.
Bromberg, Jacqueline
Omuro, Antonio M.
Hsieh, James J.
Mellinghoff, Ingo K.
Staton, Kevin
Pressl, Christina
Beattie, Bradley J.
Zanzonico, Pat B.
Gerecitano, John F.
Kelsen, David P.
Weber, Wolfgang
Lyashchenko, Serge K.
Kung, Hank F.
Lewis, Jason S.
RADIOLOGY, 2018, 287 (02) : 667 - 675
[36] The role [18F]-(2S,4R)-4-Fluoroglutamine as a new positron emission tomography tracer in Myeloma in vivo models.
Toscani, Denise
Valtorta, Silvia
Chiu, Martina
Sartori, Andrea
Coliva, Angela
Brevi, Arianna
Taurino, Giuseppe
Grioni, Matteo
Ni, Livia Ruffi
Vacondio, Federica
Zanardi, Franca
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S47 - S48
[37] Cellular glutamine pool size change in response to glutaminase inhibition detected by [18F](2S, 4R) 4-fluoroglutamine PET
Pantel, Austin
Lee, Sharon
Li, Shihong
Doot, Robert
Mach, Robert
Mankoff, David
Zhou, Rong
JOURNAL OF NUCLEAR MEDICINE, 2017, 58
[38] (2S,4R)-4-[18F]Fluoroglutamine as a PET Indicator for Bone Marrow Metabolism Dysfunctional: from Animal Experiments to Clinical Application
Hua Zhu
Fei Liu
Yan Zhang
Jianhua Yang
Xiaoxia Xu
Xiaoyi Guo
Teli Liu
Nan Li
Lin Zhu
Hank F. Kung
Zhi Yang
Molecular Imaging and Biology, 2019, 21 : 945 - 953
[39] (2S,4R)-4-[18F]Fluoroglutamine as a PET Indicator for Bone Marrow Metabolism Dysfunctional: from Animal Experiments to Clinical Application
Zhu, Hua
Liu, Fei
Zhang, Yan
Yang, Jianhua
Xu, Xiaoxia
Guo, Xiaoyi
Liu, Teli
Li, Nan
Zhu, Lin
Kung, Hank F.
Yang, Zhi
MOLECULAR IMAGING AND BIOLOGY, 2019, 21 (05) : 945 - 953
[40] PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[18F]Fluoroglutamine
Alyssa C. Pollard
Vincenzo Paolillo
Bhasker Radaram
Sarah Qureshy
Li Li
Tapati Maity
Lei Wang
Md. Nasir Uddin
Christopher G. Wood
Jose A. Karam
Mark D. Pagel
David Piwnica-Worms
Steven W. Millward
Natalie Wall Fowlkes
William Norton
Brian J. Engel
Federica Pisaneschi
Niki M. Zacharias
Molecular Imaging and Biology, 2022, 24 : 959 - 972

← 1 2 3 4 5 →